ATF3 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BPS
|
MA0605.2
|
ATF3 |
glioblastoma cells |
Dox + Arvanil + BMP7 |
Permissive
Robust
|
Homo sapiens |
GSE33912
...
|
MA0605.2
|
ATF3 |
retina |
LPS |
Permissive
|
Mus musculus |
GSE54414
...
|
MA0605.2
|
ATF3 |
retina |
LPS |
Permissive
Robust
|
Mus musculus |
GSE54414
...
|
MA0605.2
|
ATF3 |
BMDM (bone marrow-derived macrophages) |
2mg/ml HDL for 6h |
Permissive
Robust
|
Mus musculus |
GSE55317
...
|
MA0605.2
|
ATF3 |
BMDM (bone marrow-derived macrophages) |
2mg/ml HDL for 6h + 100nM CpG for 4h |
Permissive
Robust
|
Mus musculus |
GSE55317
...
|
MA0605.2
|
ATF3 |
dermal fibroblasts |
overexpressed ATF3 |
Permissive
Robust
|
Homo sapiens |
GSE81403
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
lipid A 0 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
lipid A 15 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
lipid A 30 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
lipid A 60 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
lipid A 120 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0605.2
|
ATF3 |
CS1AN (Cockayne syndrome) |
Treatment: UV-C, 12 J/m2 Genotype: mutant cells |
Permissive
|
Homo sapiens |
GSE87562
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl6; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0605.2
|
ATF3 |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0605.2
|
ATF3 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BJY
|
MA0605.2
|
ATF3 |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BKC
|
MA0605.2
|
ATF3 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BKE
|
MA0605.2
|
ATF3 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BNU
|
MA0605.2
|
ATF3 |
HCT-116 (colon carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUG
|
MA0605.2
|
ATF3 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DOG
|
MA0605.2
|
ATF3 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR205FOW
|
MA0605.2
|
ATF3 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR480LIS
|
MA0605.2
|
ATF3 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR028UIU
|
MA0605.2
|
ATF3 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE55317
...
|
MA0605.2
|
ATF3 |
dermal fibroblasts |
|
Permissive
|
Homo sapiens |
GSE81403
...
|
MA0605.2
|
ATF3 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR632DCH
|
MA0605.2
|
ATF3 |
HCT-116 (colon carcinoma) |
CAMP |
Permissive
Robust
|
Homo sapiens |
GSE74355
|
MA0605.2
|
ATF3 |
HCT-116 (colon carcinoma) |
DMSO_KOATF3 |
Permissive
Robust
|
Homo sapiens |
GSE74355
|
MA0605.2
|